z-logo
open-access-imgOpen Access
Pituitary function and the response to GH therapy in patients with Langerhans cell histiocytosis: analysis of the KIMS database
Author(s) -
Philippe Touraine,
Yempabou Sagna,
Anders Mattsson,
Pia Burman,
André P. van Beek,
Martin Carlsson,
Ferah Aydin,
Ulla FeldtRasmussen,
Cecilia CamachoHübner
Publication year - 2022
Publication title -
european journal of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 148
eISSN - 1479-683X
pISSN - 0804-4643
DOI - 10.1530/eje-22-0160
Subject(s) - langerhans cell histiocytosis , medicine , endocrinology , histiocytosis , function (biology) , biology , disease , evolutionary biology
To analyze the effectiveness and safety of growth hormone (GH) replacement treatment in adult patients with Langerhans cell histiocytosis (LCH) and GH deficiency (GHD) enrolled in KIMS (Pfizer International Metabolic Database).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom